Possible scenario
AI Bio Competition
20% Chance
OpenAI's free program accelerates competition among frontier AI firms serving life-sciences researchers. The market response depends on whether investors see the program as expanding demand for AI infrastructure or compressing margins for specialist bio-AI vendors.
Secondary impacts
- Technology +0.4%
- Healthcare +0.1%
Tickers
- SDGR-1.6%
- RXRX-1.1%
- NVDA+1.0%
Portfolio impact
S&P 500+0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.